BTF3 and colorectal carcinoma: The relative immunoreactivity score of BTF3 in the ANCT samples was 1.90 ± 0.03 (derived from immunoreactive intensity measurements), significantly lower than those determined in CRC tissue (2.61 ± 0.07) (Fig. 1g, P < 0.001).